Product
YS-HBV-002
1 clinical trial
1 indication
Indication
Chronic Hepatitis BClinical trial
A Phase I, Double-blind, Randomized, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002 in the Treatment of Chronic Hepatitis B (CHB) Infection in Adults ≥ 18 Years OldStatus: Not yet recruiting, Estimated PCD: 2024-09-30